Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
H Weishaupt, M Čančer, G Rosén… - Neuro …, 2023 - academic.oup.com
Background Malignant gliomas, the most common malignant brain tumors in adults,
represent a heterogeneous group of diseases with poor prognosis. Retroviruses can cause …
represent a heterogeneous group of diseases with poor prognosis. Retroviruses can cause …
Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice
FK Johansson, H Göransson, B Westermark - Oncogene, 2005 - nature.com
Retroviral tagging previously identified putative cancer-causing genes in a mouse brain
tumor model where a recombinant Moloney murine leukemia virus encoding the platelet …
tumor model where a recombinant Moloney murine leukemia virus encoding the platelet …
Identifying candidate genes involved in brain tumor formation
F Johansson Swartling - Upsala journal of medical sciences, 2008 - Taylor & Francis
Malignant primary brain tumors, gliomas, often overexpress both platelet-derived growth
factor (PDGF) ligands and receptors providing an autocrine and/or paracrine boost to tumor …
factor (PDGF) ligands and receptors providing an autocrine and/or paracrine boost to tumor …
[HTML][HTML] Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression
EI Fomchenko, JD Dougherty, KY Helmy, AM Katz… - PloS one, 2011 - journals.plos.org
Background Gliomas are thought to form by clonal expansion from a single cell-of-origin,
and progression-associated mutations to occur in its progeny cells. Glioma progression is …
and progression-associated mutations to occur in its progeny cells. Glioma progression is …
[HTML][HTML] Double minute amplification of mutant PDGF receptor α in a mouse glioma model
In primary brain tumors, oncogenes are frequently amplified and maintained on
extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain …
extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain …
GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background
SM Hede, I Hansson, GB Afink, A Eriksson… - Glia, 2009 - Wiley Online Library
Glioblastomas are the most common and malignant astrocytic brain tumors in human adults.
The tumor suppressor gene TP53 is commonly mutated and/or lost in astrocytic brain tumors …
The tumor suppressor gene TP53 is commonly mutated and/or lost in astrocytic brain tumors …
[HTML][HTML] Expression of alpha-type platelet-derived growth factor receptor–influenced genes predicts clinical outcome in glioma
EA Ko, H Lee, KM Sanders, SD Koh, T Zhou - Translational Oncology, 2020 - Elsevier
BACKGROUND: Alpha-type platelet-derived growth factor receptor (PDGFRα) is a cell
surface tyrosine kinase receptor for members of the platelet-derived growth factor family …
surface tyrosine kinase receptor for members of the platelet-derived growth factor family …
A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma
Background Mouse models of glioblastoma (GBM), the most aggressive primary brain tumor,
are critical for understanding GBM pathology and can contribute to the preclinical evaluation …
are critical for understanding GBM pathology and can contribute to the preclinical evaluation …
[HTML][HTML] Platelet-derived growth factor receptor alpha in glioma: a bad seed
Recent collaborative, large-scale genomic profiling of the most common and aggressive
brain tumor glioblastoma multiforme (GBM) has significantly advanced our understanding of …
brain tumor glioblastoma multiforme (GBM) has significantly advanced our understanding of …
Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor α and poly (ADP-ribose) polymerase as potential …
M Zarghooni, U Bartels, E Lee, P Buczkowicz… - Journal of clinical …, 2010 - ascopubs.org
Purpose Diffuse intrinsic pontine glioma (DIPG) is one of the most devastating of pediatric
malignancies and one for which no effective therapy exists. A major contributor to the failure …
malignancies and one for which no effective therapy exists. A major contributor to the failure …